Literature DB >> 9672206

The need for IgG2c specific antiserum when isotyping antibodies from C57BL/6 and NOD mice.

R M Martin1, J L Brady, A M Lew.   

Abstract

Isotyping and quantitation of murine IgG2a antibodies are widely performed with commercial monoclonal and polyclonal antisera raised against BALB/c IgG2a myeloma proteins. Recently it became evident that inbred mouse strains with the Igh1-b allele do not have the gene for IgG2a and instead express the IgG2c isotype. We show that commercial anti-IgG2a sera cross-react inadequately against IgG2c in immunoblot and ELISA and hence, are not suitable to detect and measure this subclass in mouse strains such as C57BL/6, C57BL/10 and NOD. We have used DNA immunization to generate polyclonal anti-IgG2c serum and demonstrated that it is essential to use IgG2c-specific antiserum to quantify accurately isotypic responses in mouse strains with the Igh1-b allele.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9672206     DOI: 10.1016/s0022-1759(98)00015-5

Source DB:  PubMed          Journal:  J Immunol Methods        ISSN: 0022-1759            Impact factor:   2.303


  146 in total

1.  Various types of Dirofilaria immitis polyproteins selectively induce a Th2-Type immune response.

Authors:  Hiroyuki Tezuka; Shinjiro Imai; Shinya Hidano; Setsuko Tsukidate; Koichiro Fujita
Journal:  Infect Immun       Date:  2003-07       Impact factor: 3.441

2.  DNA vaccination encoding glutamic acid decarboxylase can enhance insulitis and diabetes in correlation with a specific Th2/3 CD4 T cell response in non-obese diabetic mice.

Authors:  A Gauvrit; M Debailleul; A-T Vu; P Sai; J-M Bach
Journal:  Clin Exp Immunol       Date:  2004-08       Impact factor: 4.330

3.  CD40L-null NKT cells provide B cell help for specific antibody responses.

Authors:  Hemangi B Shah; Sunil K Joshi; Mark L Lang
Journal:  Vaccine       Date:  2011-09-28       Impact factor: 3.641

4.  Antigen targeting to major histocompatibility complex class II with streptococcal mitogenic exotoxin Z-2 M1, a superantigen-based vaccine carrier.

Authors:  Fiona J Radcliff; Jacelyn M S Loh; Birgit Ha; Diana Schuhbauer; James McCluskey; John D Fraser
Journal:  Clin Vaccine Immunol       Date:  2012-02-01

5.  Self-encapsulating Poly(lactic-co-glycolic acid) (PLGA) Microspheres for Intranasal Vaccine Delivery.

Authors:  Brittany A Bailey; Kashappa-Goud H Desai; Lukasz J Ochyl; Susan M Ciotti; James J Moon; Steven P Schwendeman
Journal:  Mol Pharm       Date:  2017-08-22       Impact factor: 4.939

6.  Sex-dependent effects of bisphenol A on type 1 diabetes development in non-obese diabetic (NOD) mice.

Authors:  Joella Xu; Guannan Huang; Tamas Nagy; Quincy Teng; Tai L Guo
Journal:  Arch Toxicol       Date:  2019-01-02       Impact factor: 5.153

7.  Vitamin C supplementation does not protect L-gulono-gamma-lactone oxidase-deficient mice from Helicobacter pylori-induced gastritis and gastric premalignancy.

Authors:  Chung-Wei Lee; Xiang-Dong Wang; Kuo-Liong Chien; Zhongming Ge; Barry H Rickman; Arlin B Rogers; Andrea Varro; Mark T Whary; Timothy C Wang; James G Fox
Journal:  Int J Cancer       Date:  2008-03-01       Impact factor: 7.396

8.  A deficiency in the B cell response of C57BL/6 mice correlates with loss of macrophage-mediated killing of Leishmania amazonensis.

Authors:  Katherine N Gibson-Corley; Paola M Boggiatto; Rami M Mukbel; Christine A Petersen; Douglas E Jones
Journal:  Int J Parasitol       Date:  2009-12-11       Impact factor: 3.981

9.  Accelerated progression of gastritis to dysplasia in the pyloric antrum of TFF2 -/- C57BL6 x Sv129 Helicobacter pylori-infected mice.

Authors:  James G Fox; Arlin B Rogers; Mark T Whary; Zhongming Ge; Masa Ohtani; Evelyn Kurt Jones; Timothy C Wang
Journal:  Am J Pathol       Date:  2007-11       Impact factor: 4.307

10.  CD28 costimulation is required for the expression of T-cell-dependent cell-mediated immunity against blood-stage Plasmodium chabaudi malaria parasites.

Authors:  Thomas Rummel; Joan Batchelder; Patrick Flaherty; GayeLyn LaFleur; Payal Nanavati; James M Burns; William P Weidanz
Journal:  Infect Immun       Date:  2004-10       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.